Statistics in Preclinical Pharmaceutical Research and Development

By Gunter, Bert; Holder, Dan | Journal of the American Statistical Association, September 2000 | Go to article overview

Statistics in Preclinical Pharmaceutical Research and Development


Gunter, Bert, Holder, Dan, Journal of the American Statistical Association


Although most statisticians and the public at large are familiar with the role of statistics in human clinical drug trials, advances in the basic science and technology of drug research and development (R&D) have created equally challenging and important opportunities in the preclinical arena. Preclinical pharmaceutical research encompasses all aspects of drug discovery and development, from basic research into how cells and organs work and how disease processes disrupt that work to the development, formulation, and manufacture of drugs. The activities that fall under this rubric include biological and biochemical research using in vitro ("test tube"-based) and in vivo (whole animal) experiments; genomics, the study of gene expression in cells, organisms, and populations to determine the molecular biology of disease; proteomics, the study of protein expression patterns to understand how normal and disease processes differ; design, synthesis, and selection of diverse chemical and natural product "libraries" o f compounds to screen for desirable biological activity, often via high throughput, "industrialized" drug screening assays; analytical development for drug research and manufacturing; animal testing of drug candidates for efficacy and metabolism and to determine drug toxicity, teratogenicity (fetal and growth effects), and carcinogenicity; development and scale-up of chemical and fermentation drug manufacturing processes; and drug formulation and stability testing. This list is far from complete.

To put these activities into perspective, it can easily cost more than $1 billion and require 10 to 15 years of R&D to bring out a single new drug, of which only the last 2-3 involve the FDA-reviewed human trials with which statisticians and the public are most familiar. So preclinical activities occupy the bulk of the time and scientific effort. The statistics that support this work cover a broad range of statistical methods. Sample sizes can range from longitudinal case-control studies of 10 or fewer animals (although they may produce thousands of data points from continuous monitoring using sophisticated instruments and telemetry) to hundreds of thousands or millions of multivariate records in drug screening and structure searches. All areas of statistics find useful application, but recent opportunities for nonparametric experimental design, linear and nonlinear longitudinal data modeling, high-dimensional exploration and visualization, inference using exact permutation methods and bootstrapping, and pat tern recognition, classification, and clustering of large databases are perhaps noteworthy.

Clearly, in a brief survey like this we can highlight only a couple of examples. We have chosen chemometrics and genomics because they provide good examples of the kind of interdisciplinary, data-rich, and nonstandard issues that are increasingly at the forefront of modern pharmaceutical research. But these examples are just the tip of a vast and fascinating iceberg.

1. CHEMOMETRICS

Roughly speaking, chemometrics is the statistics of (analytical) chemistry data; especially spectroscopy data. Physics and chemistry have developed an arsenal of ingenious tools to probe chemical composition and structure. (A nice internet resource for spectroscopy is www.anachem.umu.se/jumpstation.htm.) These techniques can produce (one- and two-dimensional) spectra of exquisite resolution, often with hundreds or thousands of individual peaks. Digitizing translates them to multivariate vectors of that dimensionality. Chemometrics arose because classical multivariate normal statistical methods were inadequate for such data and related matters of calibration and quality control.

One typical application will give the flavor of the issues. Suppose that one has, say, 200 unknown natural chemical extracts from various biological sources that are tested for antibiotic activity against 30 different pathogens. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • A full archive of books and articles related to this one
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Statistics in Preclinical Pharmaceutical Research and Development
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

    Already a member? Log in now.